Ashleigh Hollowell

3 weeks ago | bhbusiness.com | Ashleigh Hollowell

This is an exclusive BHB+ storyExtended-release medications to treat opioid use disorders (XR-MOUD) are highly effective. Still, the medications are consistently underutilized, despite being proven to help with treatment adherence. Providers and researchers see significant potential for XR-MOUD treatment among adolescent patients.

3 weeks ago | bhbusiness.com | Ashleigh Hollowell

An overabundance of options typically isn’t a bad thing. Yet the influx of novel ways to access therapy and mental health services – propelled by the increased attention to behavioral health during the pandemic – has left payers, providers and patients questioning what is quality and what is not. As the behavioral health industry simultaneously grapples with an ongoing quest toward standardizing measurements, the overabundant options for care have only added confusion.

3 weeks ago | bhbusiness.com | Ashleigh Hollowell

Integrating physical and behavioral health care for vulnerable populations is an ongoing challenge across industry. Two providers are bridging traditional care gaps to do just that. And they are doing that in home-based models, a care delivery method not typically seen in mental health and addiction treatment — in the homeNest Health and MiraSol Health have each launched programs aimed at improving access to behavioral health services, moving beyond incorporating telehealth for patients at home.

3 weeks ago | bhbusiness.com | Ashleigh Hollowell

It may seem contradictory to start on the opposite side of the spectrum from the payment model you aim to move into as a provider, but the best way to shift to value-based contracts could actually be embracing fee-for-service arrangements. Starting with fee-for-service models can help de-risk the transition to value-based care while helping providers create a sustainable runway for success before moving into uncharted territory for their business.

3 weeks ago | bhbusiness.com | Ashleigh Hollowell

As the Trump administration continues to redefine priorities and research around autism, keeping the industry on edge, other pressure points for providers and investors are also mounting in 2025. Network tightening, payer scrutiny, complexity in authorizations and uncertainty in staffing are creating hurdles for reimbursement negotiations, industry leaders explained at the Autism Investor Summit in April. “Naturally, as providers, we think about having adversarial relationships with payers.